Beacon Capital Management LLC (Tennessee)’s West Pharmaceutical WST Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7	Closed	-$1.53K	–	1026
2025 Q2	$1.53K	Hold	7	–	–	﹤0.01%	938
2025 Q1	$1.57K	Hold	7	–	–	﹤0.01%	984
2024 Q4	$2.29K	Sell	7 -1	-13%	-$315	﹤0.01%	872
2024 Q3	$2.4K	Buy	8 +1	+14%	+$306	﹤0.01%	959
2024 Q2	$2.31K	Hold	7	–	–	﹤0.01%	842
2024 Q1	$2.77K	Hold	7	–	–	﹤0.01%	817
2023 Q4	$2.63K	Hold	7	–	–	﹤0.01%	761
2023 Q3	$2.68K	Hold	7	–	–	﹤0.01%	799
2023 Q2	$2.68K	Buy	+7	New	+$2.5K	﹤0.01%	799

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s WST Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 7 shares — an estimated $1.53K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in WST in Q2 2023 and held it in 9 quarters. The position peaked at $2.77K in Q1 2024. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

Beacon Capital Management LLC (Tennessee) reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
Beacon Capital Management LLC (Tennessee) sold 7 West Pharmaceutical shares in Q3 2025, an estimated $1.53K.
Beacon Capital Management LLC (Tennessee) first reported a position in West Pharmaceutical in Q2 2023 and held it in 9 quarters.
Beacon Capital Management LLC (Tennessee)'s West Pharmaceutical position peaked at $2.77K in Q1 2024.
758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.